Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT02930005
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar I disorder, delusional disorder, other specified schizophrenia spectrum and other psychotic disorders, unspecified schizophrenia spectrum and other psychotic disorders
* Negative pregnancy test in females of childbearing age
Exclusion Criteria:
* Urine drug screen positive for psychostimulants such as cocaine, amphetamines and ecstasy
* Any infection, neoplasm, autoimmune disease or other primary inflammatory condition (3) Previous diagnosis of intellectual disability or dementia
* Current treatment with heparin
* Use of or allergy to non-steroidal anti-inflammatory agent or pentosan polysulfate sodium
* Current or anticipated corticosteroid use
* History of peptic ulcer disease, gastro esophageal reflux disease, or gastrointestinal bleeding
* Those on warfarin or any anticoagulant
* Current treatment with lithium or asthma medication
* Individuals with pre-existing liver, cardiac, or kidney disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT02930005
Study Brief:
Protocol Section:
NCT02930005